Heather Wakelee on the Role of Checkpoint Inhibitors in Advanced Lung Cancer.
作者信息
Wakelee Heather
出版信息
Oncology (Williston Park). 2017 Jun 15;31(6):440, 442.
PMID:28620899
Abstract
摘要
相似文献
1
Heather Wakelee on the Role of Checkpoint Inhibitors in Advanced Lung Cancer.
Oncology (Williston Park). 2017 Jun 15;31(6):440, 442.
2
Immune checkpoint inhibitors in lung cancer: an update.
Future Oncol. 2017 May;13(11):955-959. doi: 10.2217/fon-2017-0044.
3
The "value" of immune-checkpoint inhibitors for advanced lung cancer.
Respir Investig. 2017 Jul;55(4):253-254. doi: 10.1016/j.resinv.2017.04.001. Epub 2017 May 17.
4
KEYNOTE-024: Unlocking a pathway to lung cancer cure?
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1777-1780. doi: 10.1016/j.jtcvs.2017.10.155. Epub 2017 Dec 23.
5
There and back again: An immunotherapy tale.
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1771-1774. doi: 10.1016/j.jtcvs.2017.11.102. Epub 2017 Dec 23.
6
[Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers].
Ann Pathol. 2017 Feb;37(1):61-78. doi: 10.1016/j.annpat.2016.12.009. Epub 2017 Feb 3.
7
Pembrolizumab as first-line therapy in programmed death ligand 1-positive advanced lung cancer: Is it as effective as we think it is?
Cancer. 2017 Oct 15;123(20):3872-3874. doi: 10.1002/cncr.30868. Epub 2017 Jun 29.
8
PDL-1/PD1 inhibitors: antibody or antinobody?
Future Oncol. 2017 Aug;13(19):1669-1671. doi: 10.2217/fon-2017-0215. Epub 2017 Aug 23.
9
Checkpoint blockade after kidney transplantation.
Eur J Cancer. 2018 Jun;96:111-114. doi: 10.1016/j.ejca.2018.03.019. Epub 2018 Apr 26.
10
Is immune checkpoint inhibition part of standard therapy for stage III non-small cell lung cancer?
Cancer. 2018 Jul 15;124(14):2878-2880. doi: 10.1002/cncr.31557. Epub 2018 Jun 15.
Zotero 插件